课题基金 / 基金详情

ACTIVATION AND REGULATION OF NORMAL AND NEOPLASTIC CELLS

ACTIVATION AND REGULATION OF NORMAL AND NEOPLASTIC CELLS
正常细胞和肿瘤细胞的激活和调节
批准号:
3478980
负责人:
STANLEY COHEN
金额:
$66.28万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-06-01 至 1994-05-31

项目摘要

项目成果

STANLEY COHEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall goal of the proposed research is to explore mechanisms of activation and regulation of function in normal and neoplastic cells. The studies involve (a) cytoplasmic control of cell replication, (b) modification of tumor cell properties by non-cytotoxic lymphokines, (c) regulation of lymphokine production and the expression of lymphokine activity, and (d) the effects of non-immunologic growth factors on the immune response. Studies in the first category are based on our observation that mitogen- or interleukin-activated normal lymphocytes contain a cytoplasmic protein (ADR) that can induce DNA synthesis in isolated nuclei in a cell-free system. We have also found that this factor is produced consitutively by neoplastic cells. We propose to investigate this regulatory system for cell proliferation by purifying ADR, studying the mechanisms involved in its reaction with the cell nucleus, and determining the abnormalities of ADR, nucleus, and inhibitory systems in neoplastic cells. Studies in the second category are based on the premise that modification of functional properties of tumor cells by immunologic mediators may be as useful a form of tumor therapy as the more commonly attempted strategies desighed to kill tumor cells. To this end, we are studying the ability of lymphokines to inhibit tumor cell migration and inhibit binding of tumor cells to endothelium, as well as the effects of lymphokines on other aspects of tumor cell behavior. Studies in the last two categories are designed to provide insight into novel ways in which immune regulation may be achieved, with special attention to lymphokine production and the expression of lymphokine activity. To this end, various immunologic regulatory macromolecules as well as hormonal growth and regulatory factors not generally considered to be part of the immune system will be investigated. Our overall approach for this aim involves the purification and characterization of responsible factors, elucidation of their mechanism of action, investigation of possible alterations in neoplastic states, and, ultimately, attempts to manipulate the systems in which they participate for possible therapeutic effort. It is hoped that these studies will provide insights into basic mechanisms of cell growth and regulation.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Initiation of lymphocyte DNA synthesis.
淋巴细胞DNA合成的起始。
DOI: 10.1002/jcb.240450107
发表时间: 1991
期刊: Journal of cellular biochemistry
影响因子: 4
作者: [Coffman,FD, Fresa,KL, Cohen,S]
通讯作者: Cohen,S
Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
肿瘤坏死因子与 DNA 拓扑异构酶 I 和 II 抑制剂之间的协同相互作用。
DOI: --
发表时间: 1990
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Baloch,Z, Cohen,S, Coffman,FD]
通讯作者: Coffman,FD
Characteristics of DNA replication in isolated nuclei initiated by an aprotinin-binding protein.
由抑肽酶结合蛋白启动的分离细胞核中 DNA 复制的特征。
DOI: 10.1002/jcb.240510207
发表时间: 1993
期刊: Journal of cellular biochemistry
影响因子: 4
作者: [Coffman,FD, Fresa,KL, Hameed,M, Cohen,S]
通讯作者: Cohen,S
DOI: 10.1016/s0006-291x(05)80809-5
发表时间: 1992-07
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Michal Bereta;Joanna Bereta;Stanley Cohen;Marion C. Cohen]
通讯作者: Michal Bereta;Joanna Bereta;Stanley Cohen;Marion C. Cohen
13
    SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3)
    SECONDARY PREVENTION OF SMALL SUBCORTICAL STROKES (SPS3)
    Warfarin vs. Aspirin for Symptomatic Intracranial Disease
    Secondary Prevention of Small Subcortical Strokes (SPS3)
    海外基金